5ttd
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 5ttd is ON HOLD until Paper Publication Authors: Young, P.G., Kwon, H., Squire, C.J., Baker, E.N. Description: Minor pilin FctB from S. pyogenes wi...) |
|||
| (3 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Minor pilin FctB from S. pyogenes with engineered intramolecular isopeptide bond== | |
| + | <StructureSection load='5ttd' size='340' side='right'caption='[[5ttd]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[5ttd]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] and [https://en.wikipedia.org/wiki/Streptococcus_pyogenes Streptococcus pyogenes]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5TTD OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5TTD FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=GLC:ALPHA-D-GLUCOSE'>GLC</scene>, <scene name='pdbligand=PRD_900009:alpha-maltotriose'>PRD_900009</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ttd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ttd OCA], [https://pdbe.org/5ttd PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ttd RCSB], [https://www.ebi.ac.uk/pdbsum/5ttd PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ttd ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/MALE_ECOLI MALE_ECOLI] Involved in the high-affinity maltose membrane transport system MalEFGK. Initial receptor for the active transport of and chemotaxis toward maltooligosaccharides.[https://www.uniprot.org/uniprot/D2KPJ6_STRPY D2KPJ6_STRPY] | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | The overall stability of globular protein structures is marginal, a balance between large numbers of stabilizing non-covalent interactions and a destabilizing entropic term. Higher stability can be engineered by introduction of disulfide bonds, provided the redox environment is controlled. The discovery of stabilizing isopeptide bond crosslinks, formed spontaneously between lysine and asparagine (or aspartic acid) side chains in certain bacterial cell-surface proteins suggests that such bonds could be introduced by protein engineering as an alternative protein stabilization strategy. We report the first example of an isopeptide bond engineered de novo into an immunoglobulin-like protein, the minor pilin FctB from Streptococcus pyogenes. Four mutations were sufficient; lysine, asparagine and glutamic acid residues were introduced for the bond-forming reaction, with a fourth Val/Phe mutation to help steer the lysine side chain into position. The spontaneously-formed isopeptide bond was confirmed by mass spectrometry and X-ray crystallography, and was shown to increase the thermal stability by 10 degrees C compared with the wild type protein. This novel method for increasing the stability of IgG-like proteins has potential to be adopted by the field of antibody engineering, which share similar beta-clasp Ig-type domains. | ||
| - | + | Engineering a Lys-Asn isopeptide bond into an immunoglobulin-like protein domain enhances its stability.,Kwon H, Young PG, Squire CJ, Baker EN Sci Rep. 2017 Feb 16;7:42753. doi: 10.1038/srep42753. PMID:28202898<ref>PMID:28202898</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | [[Category: | + | </div> |
| - | [[Category: | + | <div class="pdbe-citations 5ttd" style="background-color:#fffaf0;"></div> |
| - | [[Category: Baker | + | |
| - | [[Category: Squire | + | ==See Also== |
| - | [[Category: Young | + | *[[Pilin 3D structures|Pilin 3D structures]] |
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Escherichia coli]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Streptococcus pyogenes]] | ||
| + | [[Category: Baker EN]] | ||
| + | [[Category: Kwon H]] | ||
| + | [[Category: Squire CJ]] | ||
| + | [[Category: Young PG]] | ||
Current revision
Minor pilin FctB from S. pyogenes with engineered intramolecular isopeptide bond
| |||||||||||
